Frontlight ResearchEarly access
Trial site
Hangzhou
- 4running trials
- 1closed trial
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- CIDP (chronic inflammatory demyelinating polyneuropathy)3 trials
- Multiple myeloma1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 35 trials
- Status
- Active, not recruiting2 trials
- Completed1 trial
- Enrolling by invitation1 trial
- Recruiting1 trial
- Lead sponsor
- Sanofi5 trials
Running trials
Recruiting
Enrolling by invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026